Jeff Fairman - 02 Mar 2022 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
VP, Research
Signature
/s/ Ron Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
02 Mar 2022
Net transactions value
$0
Form type
4
Filing time
04 Mar 2022, 19:56:12 UTC
Previous filing
28 Dec 2021
Next filing
15 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Award $0 +6,000 +56% $0.000000 16,629 02 Mar 2022 Direct F1
holding PCVX Common Stock 341,227 02 Mar 2022 By Fairman Family Trust
holding PCVX Common Stock 50,000 02 Mar 2022 By AF 2020 Irrevocable Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Award $0 +33,000 $0.000000 33,000 02 Mar 2022 Common Stock 33,000 $24.79 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Common Stock underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs vest as to 25% of the shares subject to the award on September 2, 2022 and 12.5% of the shares every six months thereafter.
F2 1/48 of shares subject to the option vest on April 2, 2022, and 1/48 of the shares vest monthly thereafter.